Found: 1
Select item for more details and to access through your institution.
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study.
- Published in:
- Cephalalgia, 2021, v. 41, n. 13, p. 1285, doi. 10.1177/03331024211024160
- By:
- Publication type:
- Article